PCN28 COST-UTILITY ANALYSIS IN A SPANISH SETTING OF ADJUVANT THERAPY WITH TRASTUZUMAB (HERCEPTIN) IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66565-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)66565-5/fulltext
Section Title :
Section Order :
401
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66565-5&doi=10.1016/S1098-3015(10)66565-5